Chemokine Receptor Ccr2 Deficiency Reduces Renal Disease and Prolongs Survival in MRL/lpr Lupus-Prone Mice-Reference-Cited by-同舟云学术

Chemokine Receptor Ccr2 Deficiency Reduces Renal Disease and Prolongs Survival in MRL/lpr Lupus-Prone Mice

Published:2005-11-02 Issue:12 Volume:16 Page:3592-3601
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

de Lema Guillermo Pérez,Maier Holger,Franz Tobias J.,Escribese Maríia,Chilla Silvia,Segerer Stephan,Camarasa Natalia,Schmid Holger,Banas Bernhard,Kalaydjiev Svetoslav,Busch Dirk H.,Pfeffer Klaus,Mampaso Francisco,Schlöndorff Detlef,Luckow Bruno

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference50 articles.

1. Lahita RG: Systemic Lupus Erythematosus, New York, Academic Press, 2004

2. Murine Models of Systemic Lupus Erythematosus

3. Use of Genetic Knockouts to Modulate Disease Expression in a Murine Model of Lupus, MRL/lpr Mice

4. The Role of Complement in the Development of Systemic Lupus Erythematosus

5. Monocyte Chemoattractant Protein 1–Dependent Leukocytic Infiltrates Are Responsible for Autoimmune Disease in Mrl-Faslpr Mice

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CCL2–CCR2 axis determines whether glomerular endocapillary hypercellularity or wire‐loop lesions develop through glomerular macrophage and neutrophil infiltration in lupus nephritis;The Journal of Pathology;2024-07-26

2. Spatial characterization of interface dermatitis in cutaneous lupus reveals novel chemokine ligand-receptor pairs that drive disease;2024-01-06

3. Identification of effective CCR2 inhibitors for cancer therapy using humanized mice;The Journal of Biochemistry;2023-11-08

4. MCP‐1/CCR2 axis is involved in the regulation of γδT cells in lupus nephritis;Scandinavian Journal of Immunology;2023-06-16

5. NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions;JCI Insight;2023-04-10